-

Susan G. Komen® Announces CEO Paula Schneider to Step Down

Schneider to Assume New Role as Honorary Vice Chair

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today announced that President and Chief Executive Officer Paula Schneider has shared that she will step down from the CEO role after seven years of transformational leadership. Schneider will continue to serve the organization as Honorary Vice Chair, using her renowned and respected voice to support the urgent mission to end deaths from breast cancer in our lifetime.

During her tenure, Schneider led Komen through a critical period, transforming Komen’s national network of local affiliate organizations into a single, unified entity to increase efficiency and impact across the country. Under her leadership, Komen accelerated research, advocacy, community outreach, and patient care, leaving the organization well-positioned for future success. To date, Komen has invested more than $3.5 billion in these critical areas, advancing its mission to save lives and to prevent and cure breast cancer.

“I’m enormously proud of the meaningful work our team has done and the progress we’ve made in our shared mission to save lives,” said Paula Schneider. “Our mission has never been more urgent. In my new role at Komen, I will focus on continuing to broadcast our message to extend our reach and heighten our impact.”

“The Board of Directors is deeply grateful to Paula for her exceptional service and unwavering commitment to Komen’s mission,” said the Chair of the Board of Directors, Ed Dandridge. “Her leadership has been instrumental in transforming this organization. Komen is well-positioned to enter its next chapter, and we look forward to identifying the leader who will follow in her footsteps to guide Komen’s continued transformation.”

During the leadership transition, a committee comprised of Komen board members and Komen senior leaders will guide Komen’s executive responsibilities while the Board conducts a national search for a successor. This collaborative interim leadership model ensures continuity, stability, and continued momentum across the organization’s mission priorities.

The leadership succession comes at a time of strength for Susan G. Komen – which has a clear mission, a pivotal role in supporting breakthrough research and the unwavering respect and support of the breast cancer community. Schneider will remain a visible presence at Komen events, thought leadership forums, and community initiatives.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Media contact:
press@komen.org

Susan G. Komen


Release Versions

Contacts

Media contact:
press@komen.org

More News From Susan G. Komen

Legislation Eliminates Financial Barriers to Critical Breast Imaging, Would Help Thousands Across Hawaii Afford Care They Require

HONOLULU--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization commends Representative Lauren Matsuomto (R-Mililani) introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening. The exorbitant out-of-pocket costs associated with this critical breast imaging, ranging from hundreds to thousands of dollars, often force individual...

Breast Cancer 2026 Progress Outlook: New Research Discoveries and Opportunities

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today issued its 2026 Breast Cancer Progress Outlook. New data shows the U.S. breast cancer death rate has declined 44% between its peak in 1989 and 2023 — averting an estimated 546,000 deaths due largely to advances in treatment and earlier detection through screening. Yet breast cancer remains an urgent public health challenge. Incidence of invasive breast cancer has been rising since the mid-2000s, incr...

A Night to Remember: Susan G. Komen® and Trisha Yearwood Announce Star-Studded Lineup for The Second Annual "Band As One Nashville Concert for the Cure" at The Opry House

NASHVILLE, Tenn.--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, and country music icon Trisha Yearwood, today announced the confirmed line up for the second annual “Band As One Nashville Concert for the Cure: Trisha Yearwood & Friends” on March 22, 2026. This year’s event will celebrate those that have been impacted by breast cancer at a new location: The historic Opry House. Yearwood will return as the event headliner along with some of music’s most reco...
Back to Newsroom